Fuan Pharmaceutical (Group) Co., Ltd. Class A

Fuan Pharmaceutical (Group) Co., Ltd. Class A

SSZSE:300194
3.49
CNY
-0.04
(-1.13%)
0.03EPS
130.64P/E
4.63BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.47
0.59
0.87
1.11
1.76
2.22
2.37
2.04
2.07
2.01
2.17
2.05
1.35
1.41
Basic EPS, GAAP
0.05
0.06
0.08
0.19
0.24
-0.3
0.25
0.18
-0.25
0.17
0.19
0.24
0.06
0.03
Free Cash Flow per Basic Share
-0.11
-0.11
0.08
0.19
0.31
0.11
0.06
-0.16
-0.13
-0.04
0.09
0.05
0.16
- -
Dividend per Share
0.05
0.05
0.04
0.04
0.07
0.1
- -
0.06
0.07
0.02
0.08
0.07
0.08
0.06
Book Value per Share
2.18
2.19
2.52
3.33
3.51
3.1
3.35
3.45
3.14
3.32
3.48
3.69
3.67
3.72
Tangible Book Value per Share
2.01
1.99
1.86
1.92
2.11
2.19
2.36
1.88
2.25
2.44
2.81
3.02
3.07
3.13
Basic Weighted Avg Shares
767
762
811
1,168
1,187
1,200
1,171
1,163
1,188
1,204
1,220
1,166
1,283
1,167
Sales/Revenue/Turnover
358
449
708
1,297
2,091
2,669
2,781
2,368
2,453
2,422
2,648
2,391
1,738
1,648
Operating Margin (%)
5.45
7.77
9.67
20.2
15.17
10.12
9.94
8.35
7.81
6.68
9.04
12.89
5.54
9.14
Depreciation Expense
34
46
85
119
147
141
144
156
174
184
209
199
205
- -
Net Income, GAAP
38
46
65
222
285
-360
293
209
-297
205
232
280
77
35
Effective Tax Rate (%)
12.71
15.05
14.16
13.68
14.7
- -
10.33
14.66
- -
- -
19.27
10.9
8.12
33.45
Profit Margin (%)
10.72
10.19
9.17
17.11
13.62
-13.49
10.53
8.84
-12.1
8.45
8.76
11.7
4.43
2.11
Working Capital
1,053
1,018
857
759
1,019
1,183
1,330
888
797
640
931
839
1,107
1,011
LT Debt
- -
- -
- -
- -
- -
- -
- -
124
264
305
489
194
406
247
Total Equity
1,725
1,708
2,136
3,964
4,171
3,694
3,987
4,555
3,866
3,946
4,149
4,398
4,366
4,430
Return on Invested Capital (%)
2.19
2.66
3.35
6.98
6.81
- -
7.38
4.42
- -
- -
4.95
5.63
1.51
0.62
Return on Capital (%)
2.26
2.67
3.53
7.4
6.98
- -
7.48
4.79
- -
- -
5.22
5.96
1.91
0.89
Return on Common Equity (%)
2.25
2.68
3.38
7.28
7
-9.15
7.63
5.18
-7.58
5.33
5.73
6.55
1.76
0.78

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
397
344
296
LT Borrowings
251
251
246
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,190
1,190
1,190
Market Capitalization
4,866
4,021
4,628

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
1,815
1,840
1,753
Cash, Cash Equivalents & STI
920
900
807
Accounts Receivable, Net
143
151
125
Inventories
651
689
718
Total Current Liabilities
808
825
742
Payables & Accruals
- -
- -
- -
ST Debt
397
344
296
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.89%
-0.53%
-0.74%
Free Cash Flow
-43.8%
-52.34%
229.94%
Net Income, GAAP
-61.51%
-89.84%
-72.49%
Sales/Revenue/Turnover
13.6%
-5.07%
-27.31%
Total Cash Common Dividend
323.55%
39.58%
24.67%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
809
624
562
396
2,391
2025
468
453
- -
423
1,738
2026
407
432
385
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.1
0.08
0.07
-0.02
0.24
2025
0.06
0.04
- -
-0.08
0.06
2026
0.05
0.03
0.02
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.05
- -
- -
0.07
2025
- -
0.05
- -
- -
0.08
2026
- -
0.05
- -
- -
- -

Company Description

CEO
Lu Wang
Full Time Employees
2,988
Sector
Health technology
Industry
Pharmaceuticals: major
Address
No. 1, Huanan 1st Road Chongqing CH China 401121
IPO Date
Mar 11, 2011
Business
{"tool_uses":[{"recipient_name":"functions.search_web","parameters":{"queries":["Fuan Pharmaceutical Group Co Ltd latest company changes 2024 2025","Fuan Pharmaceutical Group Co Ltd product portfolio","Fuan Pharmaceutical Group Co Ltd business segments and geographic operations"]}}]}